Literature DB >> 17040304

Pain management in fulminating ulcerative colitis.

Michelle White1, Neil Shah, Keith Lindley, Adrian Lloyd-Thomas, Mark Thomas.   

Abstract

BACKGROUND: Toxic megacolon is a life-threatening complication of ulcerative colitis (UC) characterized by systemic toxicity, loss of blood per rectum and severe pain. Pain management is challenging in these patients because nonsteroidal anti-inflammatory drugs may exacerbate bleeding and opioids are contraindicated because they adversely affect bowel peristalsis causing an increased risk of colonic perforation.
METHODS: We describe three episodes of fulminating UC in two children in whom ketamine analgesia was used. Our protocol for a low-dose continuous ketamine infusion with either nurse-controlled analgesia (NCA) or patient-controlled analgesia (PCA) bolus administration is presented and a review of the literature regarding the use of ketamine analgesia in children is discussed.
RESULTS: Low-dose ketamine N/PCA with a continuous background infusion provided satisfactory analgesia and none of our children reported adverse effects.
CONCLUSIONS: We have demonstrated the safe and effective use of ketamine analgesia in children with toxic megacolon, a condition in which the child is in severe pain and morphine is contraindicated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17040304     DOI: 10.1111/j.1460-9592.2006.01913.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  3 in total

1.  Postoperative Pain Management in Patients With Ulcerative Colitis.

Authors:  Norika Katagiri; Ryutaro Sakai; Takashi Izutsu; Hiromasa Kawana; Shigekazu Sugino; Kanta Kido
Journal:  Anesth Prog       Date:  2020-09-01

2.  Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior.

Authors:  Bruk Getachew; Rachel E Reyes; Daryl L Davies; Yousef Tizabi
Journal:  Clin Pharmacol Transl Med       Date:  2019-05-05

3.  Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.

Authors:  Bruk Getachew; Joseph I Aubee; Richard S Schottenfeld; Antonei B Csoka; Karl M Thompson; Yousef Tizabi
Journal:  BMC Microbiol       Date:  2018-12-22       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.